Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSE and Xylitol (Xlear) in Acute COVID-19 Infection
NCT04854486Phase 3Withdrawn
- Sponsor
- Larkin Community Hospital
- Start
- Dec 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nasal saline in coronavirus disease 2019 (COVID-19), sponsored by Larkin Community Hospital. Planned start Dec 2021; status: withdrawn.
02
Drugs
nasal saline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04854486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04854486.